PHILADELPHIA--(BUSINESS WIRE)--PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is ...

The future of aseptic small-batch manufacturing isn’t just about leading. Manufacturers who embrace automation, rethink ...

Symbiosis Pharmaceutical Services passed its recent audit conducted by the UK’s Medicines and Healthcare products Regulatory ...

Acquisition creates a world-class large-scale manufacturing hub in San Diego region with state-of-the-art aseptic facilities ...

CDMOs are crucial partners in alum-based vaccine production, managing aseptic filling with precision and efficiency.

Along with PCI's own robust infrastructure expansions, acquisition furthers CDMO's recent growth in sterile fill-finish, advanced drug delivery ...

PCI Pharma Services ("PCI") – a leading global contract development and manufacturing organization (CDMO) focused on ...

PCI Pharma Services (“PCI”) – a leading global ... Inc. (“Althea”), a US-based sterile fill-finish CDMO and 100% subsidiary of Japan-based Ajinomoto Co., Inc. Scheduled for completion ...